0000899243-20-029733.txt : 20201029 0000899243-20-029733.hdr.sgml : 20201029 20201029194521 ACCESSION NUMBER: 0000899243-20-029733 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201027 FILED AS OF DATE: 20201029 DATE AS OF CHANGE: 20201029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Koppel Adam CENTRAL INDEX KEY: 0001578965 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 201274248 MAIL ADDRESS: STREET 1: C/O BROOKSIDE CAPITAL, LLC STREET 2: JOHN HANCOCK TOWER, 200 CLARENDON ST CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2020-10-27 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001578965 Koppel Adam C/O BAIN CAPITAL LIFE SCIENCES INVESTORS 200 CLARENDON STREET BOSTON MA 02116 1 0 0 0 Common Stock 338120 I See footnotes Represents shares of Common Stock held by BC Perception Holdings, LP ("BC Perception"). Adam Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. /s/ Adam Koppel 2020-10-29